BEAMBeam Therapeutics Inc.
$25.71+5.7% 1Y
$25.71
$20.6052 weeks$35.53
Is the price fair?
What BEAM's price assumes
Beam Therapeutics Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 22.4× revenue.
22.4
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 3.27
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 15.6
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 3.27
- EV / EBIToperating margin −242%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 15.6
- Market capitalisation
- $3.49B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks